Comparison Overview

Korea Biomedical Review

VS

Guia Marítimo

Korea Biomedical Review

76-1 Dongmak-ro, Mapo-gu, Seoul, 04074, KR
Last Update: 2026-01-21
View Profile
Between 750 and 799
http://www.koreabiomed.com/

Korea Biomedical Review (KBR) is an online English newspaper dedicated to delivering essential Korean healthcare news globally. We offer critical information to professionals, scholars, policymakers, and business individuals with an interest in Korea’s pharmaceutical, biotech, and digital health sectors. Founded in February 2017, KBR is an integral part of The Korean Doctors’ Weekly (www.docdocdoc.co.kr), a media company established by a network of Korean doctors in 1992. With a distinguished 30-year history in the healthcare media industry, The Korean Doctors’ Weekly stands as the most trusted and influential medical newspaper in its sector. In addition to publishing newspapers and producing over 100 books on healthcare, the company hosts a 30-minute audio program airing seven times a week.

NAICS: 5191311
NAICS Definition: Internet Publishing and Broadcasting and Web Search Portals
Employees: 4
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Guia Marítimo

Estrada Vereador Benedito Candido Ribeiro, 1403, Letra U, São Bento do Sapucaí, São Paulo, BR, 12490000
Last Update: 2026-01-22
Between 750 and 799
http://www.guiamaritimo.com.br

Fundado em 1992 como parte da Editora Update Ltda, o Guia Marítimo desempenha um papel crucial na formação e evolução do mercado ao longo de 30 anos. Reconhecido por criações como a Intermodal South América, A Hora da Cabotagem, o Cool Logistics Americas, o Carga de Projeto e o Zarpar.com, o Guia Marítimo mantém-se como a mais valiosa e completa fonte do setor de logística, promovendo conexões significativas. Sempre inovadores, aqui, no Guia Marítimo, é o ponto de encontro para toda a cadeia da logística integrada. Orientamos empresas para a melhor rota no comércio exterior. Navegamos com determinação rumo à sustentabilidade, explorando energias renováveis, hidrogênio verde, combustíveis alternativos para grandes modais, monitoramento dos escopos 1, 2 e 3 de descarbonização e metas ESG na cadeia de suprimentos. Comprometidos com a liderança na transformação do setor, elevamos padrões de responsabilidade e inovação. Convidamos todos a colaborarem conosco na construção de um futuro mais verde e eficaz para a logística integrada.

NAICS: 5191311
NAICS Definition: Internet Publishing and Broadcasting and Web Search Portals
Employees: 4
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/koreakbr.jpeg
Korea Biomedical Review
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/guiamaritimo.jpeg
Guia Marítimo
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Korea Biomedical Review
100%
Compliance Rate
0/4 Standards Verified
Guia Marítimo
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Internet News Industry Average (This Year)

No incidents recorded for Korea Biomedical Review in 2026.

Incidents vs Internet News Industry Average (This Year)

No incidents recorded for Guia Marítimo in 2026.

Incident History — Korea Biomedical Review (X = Date, Y = Severity)

Korea Biomedical Review cyber incidents detection timeline including parent company and subsidiaries

Incident History — Guia Marítimo (X = Date, Y = Severity)

Guia Marítimo cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/koreakbr.jpeg
Korea Biomedical Review
Incidents

No Incident

https://images.rankiteo.com/companyimages/guiamaritimo.jpeg
Guia Marítimo
Incidents

No Incident

FAQ

Both Korea Biomedical Review company and Guia Marítimo company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

Historically, Guia Marítimo company has disclosed a higher number of cyber incidents compared to Korea Biomedical Review company.

In the current year, Guia Marítimo company and Korea Biomedical Review company have not reported any cyber incidents.

Neither Guia Marítimo company nor Korea Biomedical Review company has reported experiencing a ransomware attack publicly.

Neither Guia Marítimo company nor Korea Biomedical Review company has reported experiencing a data breach publicly.

Neither Guia Marítimo company nor Korea Biomedical Review company has reported experiencing targeted cyberattacks publicly.

Neither Korea Biomedical Review company nor Guia Marítimo company has reported experiencing or disclosing vulnerabilities publicly.

Neither Korea Biomedical Review nor Guia Marítimo holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Korea Biomedical Review company nor Guia Marítimo company has publicly disclosed detailed information about the number of their subsidiaries.

Both Korea Biomedical Review company and Guia Marítimo company employ a similar number of people globally.

Neither Korea Biomedical Review nor Guia Marítimo holds SOC 2 Type 1 certification.

Neither Korea Biomedical Review nor Guia Marítimo holds SOC 2 Type 2 certification.

Neither Korea Biomedical Review nor Guia Marítimo holds ISO 27001 certification.

Neither Korea Biomedical Review nor Guia Marítimo holds PCI DSS certification.

Neither Korea Biomedical Review nor Guia Marítimo holds HIPAA certification.

Neither Korea Biomedical Review nor Guia Marítimo holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.

Published
Date
2026-01-23
Updated
Date
2026-01-23
Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
References
Description

A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References
Description

A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References
Description

A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.

Published
Date
2026-01-23
Updated
Date
2026-01-23
Risk Information
cvss3
Base: 6.0
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
cvss4
Base: 6.0
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.

Published
Date
2026-01-23
Updated
Date
2026-01-23
References